Conference Coverage

Factor XI inhibitor trims DVTs after knee replacement surgery

Publish date: February 20, 2015

 

AT ASH 2014

References

Isis Pharmaceuticals funded the study. Dr. Büller disclosed ties with Isis, Daiichi-Sankyo, Bayer Healthcare, Pfizer, and Bristol-Myers Squibb. Dr. Flaumenhaft reported having no disclosures.

pwendling@frontlinemedcom.com

Pages

Recommended Reading

VIDEO: Consider cognitive function in elderly before surgery
MDedge Surgery
Same-day combined ERCP and cholecystectomy: achievable and cost effective
MDedge Surgery
Three-minute assessment detected most cases of delirium
MDedge Surgery
Decompression can save lives in ventricular trapping
MDedge Surgery
Extended use of oral anticoagulants reduces VTE recurrence
MDedge Surgery
Nonoperative management okay after draining diverticular-associated abscess
MDedge Surgery
Palliative consult helps geriatric trauma patients avoid futile interventions
MDedge Surgery
M.O.R.E. means less delirium in ICU
MDedge Surgery
Postop pancreatectomy complications most deadly in elderly
MDedge Surgery
Pain control with ketorolac appears safe after pediatric heart surgery
MDedge Surgery